Khiron Life Sciences Corp.
Rank 58
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$0.4094
USD
-1.67%
Market cap
$46,643,324
Total volume
$384,507
Shares outstanding
113,927,120
Rank 58
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$198,975
|
51.75% |
$0.4094
|
| KHRNF |
Total volume
$185,532
|
48.25% |
Stock price
$0.4200
|
Chart